Iterum Therapeutics

NASDAQ: ITRM · Real-Time Price · USD
0.86
0.04 (4.88%)
At close: Aug 15, 2025, 12:29 PM

Iterum Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
24.13M 6.07M 21.09M 27.45M
Short-Term Investments
n/a 17.86M 39.75M 53.94M
Long-Term Investments
n/a n/a -35K 64K
Other Long-Term Assets
39K 63K 4.21M 6.64M
Receivables
66K 233K n/a 1.21M
Inventory
n/a n/a -1.85M -3.13M
Other Current Assets
65K n/a n/a 37K
Total Current Assets
24.79M 25.6M 60.84M 81.34M
Property-Plant & Equipment
23K 600K 69K 91K
Goodwill & Intangibles
19.75M n/a 1.72M 3.44M
Total Long-Term Assets
19.81M 663K 6M 10.16M
Total Assets
44.59M 26.26M 66.83M 91.51M
Account Payables
251K 5M 2.77M 878K
Deferred Revenue
n/a n/a -332K -2.5M
Short-Term Debt
14.46M n/a n/a 1.63M
Other Current Liabilities
240K 761K 1.94M 9.05M
Total Current Liabilities
17.61M 13.52M 196K 6.06M
Long-Term Debt
31.07M 18.96M 28.47M 24.9M
Other Long-Term Liabilities
n/a 188K n/a 3.44M
Total Long-Term Liabilities
31.07M 19.14M 38.64M 35.22M
Total Liabilities
48.68M 32.66M 38.83M 41.27M
Total Debt
45.53M 18.96M 28.47M 24.9M
Common Stock
315K 135K 126K 1.83M
Retained Earnings
-486.07M -461.3M -422.93M -378.49M
Comprehensive Income
n/a 1K -350K n/a
Shareholders Equity
-4.08M -6.4M 28M 50.23M
Total Investments
n/a 17.86M 39.71M 53.94M